Effects of resistin expression on glucose metabolism and hepatic insulin resistance
Autor: | Yan Li, Fangping Li, Juan He, Li Yan, Zhao-Fan Luo, Zhi-zhen Li |
---|---|
Rok vydání: | 2009 |
Předmět: |
Blood Glucose
Male medicine.medical_specialty endocrine system diseases Endocrinology Diabetes and Metabolism Blotting Western Genetic Vectors Gene Expression AMP-Activated Protein Kinases Carbohydrate metabolism Adenoviridae Mice Endocrinology Insulin resistance AMP-activated protein kinase Internal medicine Glucose Intolerance medicine Animals Insulin Resistin RNA Messenger biology Reverse Transcriptase Polymerase Chain Reaction Chemistry nutritional and metabolic diseases AMPK Fasting Metabolism medicine.disease Recombinant Proteins Enzyme Activation Mice Inbred C57BL Glucose Liver Glucose-6-Phosphatase biology.protein Decreased glucose tolerance Phosphoenolpyruvate Carboxykinase (GTP) Insulin Resistance Phosphoenolpyruvate carboxykinase Glycogen hormones hormone substitutes and hormone antagonists |
Zdroj: | Endocrine. 35:243-251 |
ISSN: | 1559-0100 1355-008X |
DOI: | 10.1007/s12020-009-9148-4 |
Popis: | In order to observe the effect of increased serum resistin on glucose metabolism, insulin sensitivity, and hepatic insulin resistance (IR), mice were intravenously injected with recombinant adenovirus carrying the resistin gene (Adv-resistin-EGFP). Changes in hepatic glucose metabolism were observed using the Periodic Acid-Schiff method. Hepatic AMP-activated protein kinase (AMPK) activation was assessed by Western blot analysis, and glucose-6-phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase (PEPCK) mRNA expression was determined using real-time RT-PCR. Although no effect on fasting blood glucose was detected, increased fasting insulin levels, decreased glucose tolerance and insulin sensitivity, and reduced hepatic glycogen levels and AMPK activation were seen in the Adv-resistin-EGFP mice. Finally, elevated G6Pase and PEPCK mRNA expression levels were detected upon overexpression of resistin. Resistin may inhibit hepatic AMPK activity, which results in elevated expression of gluconeogenic enzymes thereby affecting glucose metabolism and leading to decreased glycogen storage that contributes to the development of hepatic IR. |
Databáze: | OpenAIRE |
Externí odkaz: |